Amneal Pharmaceuticals (AMRX) Inventory Average (2018 - 2026)

Amneal Pharmaceuticals has reported Inventory Average for 9 years, with the latest figure at $659.8 million in Q2 2026.

• On a quarterly basis, Inventory Average rose 9.02% year-over-year to $659.8 million in Q2 2026; TTM through Jun 2026 was $659.8 million, a 9.02% increase from a year earlier, with the FY2025 full-year figure at $609.4 million, up 2.09% from the prior year.
• Inventory Average was $659.8 million for Q2 2026 at Amneal Pharmaceuticals, up from $624.0 million in the prior quarter.
• The five-year high for Inventory Average was $659.8 million in Q2 2026, with the low at $500.8 million in Q1 2022.
• Average Inventory Average over 5 years is $576.1 million, with a median of $577.5 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Inventory Average gained 0.99% in 2025, then climbed 9.02% in 2026.
• Over 5 years, Inventory Average stood at $537.3 million in 2022, then rose by 7.75% to $578.9 million in 2023, then rose by 4.4% to $604.4 million in 2024, then climbed by 0.99% to $610.4 million in 2025, then gained by 8.09% to $659.8 million in 2026.
• The last three Inventory Average figures came in at $659.8 million (Q2 2026), $624.0 million (Q1 2026), and $610.4 million (Q4 2025), per Business Quant data.